⟵ Back to Search Results

BGB-3111-1002

Completed

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

Beigene Study ID info

BGB-3111-1002

ClinicalTrials.gov ID info

NCT03189524

China Drug Trials ID info

CTR20160204

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan